232 related articles for article (PubMed ID: 18779884)
1. Societal cost of skin cancer in Sweden in 2005.
Tinghög G; Carlsson P; Synnerstad I; Rosdahl I
Acta Derm Venereol; 2008; 88(5):467-73. PubMed ID: 18779884
[TBL] [Abstract][Full Text] [Related]
2. Costs and quality of life of multiple sclerosis in Sweden.
Berg J; Lindgren P; Fredrikson S; Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
[TBL] [Abstract][Full Text] [Related]
3. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
[TBL] [Abstract][Full Text] [Related]
5. Cost of skin cancer in England.
Morris S; Cox B; Bosanquet N
Eur J Health Econ; 2009 Jul; 10(3):267-73. PubMed ID: 18791757
[TBL] [Abstract][Full Text] [Related]
6. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
Chevalier J; Bonastre J; Avril MF
Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
[TBL] [Abstract][Full Text] [Related]
7. Cost-of-illness of melanoma in Europe - a systematic review of the published literature.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):504-510. PubMed ID: 30408246
[TBL] [Abstract][Full Text] [Related]
8. The cost of treating type 2 diabetes (CODEIRE).
Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
[TBL] [Abstract][Full Text] [Related]
9. Kidney cancer.
Wallen EM; Pruthi RS; Joyce GF; Wise M;
J Urol; 2007 Jun; 177(6):2006-18; discussion 2018-9. PubMed ID: 17509280
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer--prevalence-based healthcare costs.
Norlund A; Alvegård T; Lithman T; Merlo J; Noreen D
Scand J Urol Nephrol; 2003; 37(5):371-5. PubMed ID: 14594683
[TBL] [Abstract][Full Text] [Related]
11. Costs of illness for melanoma and nonmelanoma skin cancer in Denmark.
Bentzen J; Kjellberg J; Thorgaard C; Engholm G; Phillip A; Storm HH
Eur J Cancer Prev; 2013 Nov; 22(6):569-76. PubMed ID: 23542376
[TBL] [Abstract][Full Text] [Related]
12. Diabetes: the cost of illness in Sweden.
Henriksson F; Jönsson B
J Intern Med; 1998 Dec; 244(6):461-8. PubMed ID: 9893099
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of skin cancer prevention in Australia.
Shih ST; Carter R; Sinclair C; Mihalopoulos C; Vos T
Prev Med; 2009 Nov; 49(5):449-53. PubMed ID: 19747936
[TBL] [Abstract][Full Text] [Related]
15. Age-specific direct healthcare costs attributable to diabetes in a Swedish population: a register-based analysis.
Wiréhn AB; Andersson A; Ostgren CJ; Carstensen J
Diabet Med; 2008 Jun; 25(6):732-7. PubMed ID: 18435778
[TBL] [Abstract][Full Text] [Related]
16. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
17. The Swedish cost burden of overweight and obesity--evaluated with the PAR approach and a statistical modelling approach.
Odegaard K; Borg S; Persson U; Svensson M
Int J Pediatr Obes; 2008; 3 Suppl 1():51-7. PubMed ID: 18278633
[TBL] [Abstract][Full Text] [Related]
18. The Royal Flying Doctor Service primary care skin cancer clinic: a pilot program for remote Australia.
Scrace M; Margolis SA
Rural Remote Health; 2009; 9(1):1048. PubMed ID: 19239334
[TBL] [Abstract][Full Text] [Related]
19. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France.
Clerc L; Jooste V; Lejeune C; Schmitt B; Arveux P; Quantin C; Faivre J; Bouvier AM
Eur J Health Econ; 2008 Nov; 9(4):361-7. PubMed ID: 18030510
[TBL] [Abstract][Full Text] [Related]
20. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]